Dual Regulation of the Transcriptional Activity of Nrf1 by β-TrCP- and Hrd1-Dependent Degradation Mechanisms

REFERENCES

• Bagola, K., M. Mehnert, E. Jarosch, and T. Sommer. 2011. Protein dislocation from the ER. Biochim. Biophys. Acta 1808:925–936.
   PubMed Web of Science ®Google Scholar
• Brown, M. S., J. Ye, R. B. Rawson, and J. L. Goldstein. 2000. Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell 100:391–398.
   PubMed Web of Science ®Google Scholar
• Chan, J. Y., et al. 1998. Targeted disruption of the ubiquitous CNC-bZIP transcription factor, Nrf-1, results in anemia and embryonic lethality in mice. EMBO J. 17:1779–1787.
   PubMed Web of Science ®Google Scholar
• Choe, K. P., A. J. Przybysz, and K. Strange. 2009. The WD40 repeat protein WDR-23 functions with the CUL4/DDB1 ubiquitin ligase to regulate nuclear abundance and activity of SKN-1 in Caenorhabditis elegans. Mol. Cell. Biol. 29:2704–2715.
   PubMed Web of Science ®Google Scholar
• Frescas, D., and M. Pagano. 2008. Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancer. Nat. Rev. Cancer 8:438–449.
   PubMed Web of Science ®Google Scholar
• Grimberg, K. B., A. Beskow, D. Lundin, M. M. Davis, and P. Young. 2011. Basic-leucine zipper protein Cnc-C is a substrate and transcriptional regulator of the Drosophila 26S proteasome. Mol. Cell. Biol. 31:897–909.
   PubMedGoogle Scholar
• Hershko, A. 2005. The ubiquitin system for protein degradation and some of its roles in the control of the cell-division cycle (Nobel lecture). Angew. Chem. Int. Ed. Engl. 44:5932–5943.
   PubMed Web of Science ®Google Scholar
• Hosokawa, N., Y. Kamiya, and K. Kato. 2010. The role of MRH domain-containing lectins in ERAD. Glycobiology 20:651–660.
   PubMedGoogle Scholar
• Kang, M. I., A. Kobayashi, N. Wakabayashi, S. G. Kim, and M. Yamamoto. 2004. Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes. Proc. Natl. Acad. Sci. U. S. A. 101:2046–2051.
   PubMed Web of Science ®Google Scholar
• Kim, J., W. Xing, J. Wergedal, J. Y. Chan, and S. Mohan. 2010. Targeted disruption of nuclear factor erythroid-derived 2-like 1 in osteoblasts reduces bone size and bone formation in mice. Physiol. Genomics 40:100–110.
   PubMed Web of Science ®Google Scholar
• Kimbrel, E. A., and A. L. Kung. 2009. The F-box protein β-TrCp1/Fbw1a interacts with p300 to enhance β-catenin transcriptional activity. J. Biol. Chem. 284:13033–13044.
   PubMedGoogle Scholar
• Kobayashi, A., et al. 2006. Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol. Cell. Biol. 26:221–229.
   PubMed Web of Science ®Google Scholar
• Kobayashi, A., et al. 2011. Central nervous system-specific deletion of transcription factor Nrf1 causes progressive motor neuronal dysfunction. Genes Cells 16:692–703.
   PubMed Web of Science ®Google Scholar
• Kobayashi, M., and M. Yamamoto. 2006. Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Adv. Enzyme Regul. 46:113–140.
   PubMedGoogle Scholar
• Lonard, D. M., and B. W. O'Malley. 2008. SRC-3 transcription-coupled activation, degradation, and the ubiquitin clock: is there enough coactivator to go around in cells? Sci. Signal. 1:pe16.
   PubMedGoogle Scholar
• Luo, J., N. L. Solimini, and S. J. Elledge. 2009. Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 136:823–837.
   PubMed Web of Science ®Google Scholar
• Meyer, L., et al. 2007. β-Trcp mediates ubiquitination and degradation of the erythropoietin receptor and controls cell proliferation. Blood 109:5215–5222.
   PubMedGoogle Scholar
• Mori, K. 2003. Frame switch splicing and regulated intramembrane proteolysis: key words to understand the unfolded protein response. Traffic 4:519–528.
   PubMedGoogle Scholar
• Muratani, M., and W. P. Tansey. 2003. How the ubiquitin-proteasome system controls transcription. Nat. Rev. Mol. Cell Biol. 4:192–201.
   PubMed Web of Science ®Google Scholar
• Nakayama, K. I., and K. Nakayama. 2006. Ubiquitin ligases: cell-cycle control and cancer. Nat. Rev. Cancer 6:369–381.
   PubMed Web of Science ®Google Scholar
• Natsume, T., et al. 2002. A direct nanoflow liquid chromatography-tandem mass spectrometry system for interaction proteomics. Anal. Chem. 74:4725–4733.
   PubMed Web of Science ®Google Scholar
• Ohta, T., et al. 2008. Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Res. 68:1303–1309.
   PubMed Web of Science ®Google Scholar
• Ohtsuji, M., et al. 2008. Nrf1 and Nrf2 play distinct roles in activation of antioxidant response element-dependent genes. J. Biol. Chem. 283:33554–33562.
   PubMed Web of Science ®Google Scholar
• Padmanabhan, B., et al. 2006. Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. Mol. Cell 21:689–700.
   PubMed Web of Science ®Google Scholar
• Page, B. D., S. J. Diede, J. R. Tenlen, and E. L. Ferguson. 2007. EEL-1, a Hect E3 ubiquitin ligase, controls asymmetry and persistence of the SKN-1 transcription factor in the early C. elegans embryo. Development 134:2303–2314.
   PubMedGoogle Scholar
• Rada, P., et al. 2011. SCF/β-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner. Mol. Cell. Biol. 31:1121–1133.
   PubMed Web of Science ®Google Scholar
• Radhakrishnan, S. K., et al. 2010. Transcription factor Nrf1 mediates the proteasome recovery pathway after proteasome inhibition in mammalian cells. Mol. Cell 38:17–28.
   PubMed Web of Science ®Google Scholar
• Ravid, T., and M. Hochstrasser. 2008. Diversity of degradation signals in the ubiquitin-proteasome system. Nat. Rev. Mol. Cell Biol. 9:679–690.
   PubMed Web of Science ®Google Scholar
• Shibata, T., et al. 2008. Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc. Natl. Acad. Sci. U. S. A. 105:13568–13573.
   PubMed Web of Science ®Google Scholar
• Singh, A., et al. 2006. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med. 3:e420.
   PubMed Web of Science ®Google Scholar
• Steffen, J., M. Seeger, A. Koch, and E. Kruger. 2010. Proteasomal degradation is transcriptionally controlled by TCF11 via an ERAD-dependent feedback loop. Mol. Cell 40:147–158.
   PubMed Web of Science ®Google Scholar
• Sykiotis, G. P., and D. Bohmann. 2010. Stress-activated cap'n'collar transcription factors in aging and human disease. Sci. Signal. 3:re3.
   PubMed Web of Science ®Google Scholar
• Treier, M., L. M. Staszewski, and D. Bohmann. 1994. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 78:787–798.
   PubMed Web of Science ®Google Scholar
• Wang, W., and J. Y. Chan. 2006. Nrf1 is targeted to the endoplasmic reticulum membrane by an N-terminal transmembrane domain. Inhibition of nuclear translocation and transacting function. J. Biol. Chem. 281:19676–19687.
   PubMed Web of Science ®Google Scholar
• Watai, Y., et al. 2007. Subcellular localization and cytoplasmic complex status of endogenous Keap1. Genes Cells 12:1163–1178.
   PubMed Web of Science ®Google Scholar
• Xing, W., et al. 2007. Nuclear factor-E2-related factor-1 mediates ascorbic acid induction of osterix expression via interaction with antioxidant-responsive element in bone cells. J. Biol. Chem. 282:22052–22061.
   PubMedGoogle Scholar
• Xu, Z., et al. 2005. Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia. Proc. Natl. Acad. Sci. U. S. A. 102:4120–4125.
   PubMed Web of Science ®Google Scholar
• Yamasaki, S., et al. 2007. Cytoplasmic destruction of p53 by the endoplasmic reticulum-resident ubiquitin ligase “Synoviolin. ” EMBO J. 26:113–122.
   PubMed Web of Science ®Google Scholar
• Zhang, J., et al. 2007. Nrf2 Neh5 domain is differentially utilized in the transactivation of cytoprotective genes. Biochem. J. 404:459–466.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., D. H. Crouch, M. Yamamoto, and J. D. Hayes. 2006. Negative regulation of the Nrf1 transcription factor by its N-terminal domain is independent of Keap1: Nrf1, but not Nrf2, is targeted to the endoplasmic reticulum. Biochem. J. 399:373–385.
   PubMedGoogle Scholar
• Zhang, Y., J. M. Lucocq, and J. D. Hayes. 2009. The Nrf1 CNC/bZIP protein is a nuclear envelope-bound transcription factor that is activated by t-butyl hydroquinone but not by endoplasmic reticulum stressors. Biochem. J. 418:293–310.
   PubMedGoogle Scholar
• Zhang, Y., J. M. Lucocq, M. Yamamoto, and J. D. Hayes. 2007. The NHB1 (N-terminal homology box 1) sequence in transcription factor Nrf1 is required to anchor it to the endoplasmic reticulum and also to enable its asparagine-glycosylation. Biochem. J. 408:161–172.
   PubMed Web of Science ®Google Scholar
• Zhao, B., L. Li, K. Tumaneng, C. Y. Wang, and K. L. Guan. 2010. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCFβ-TRCP. Genes Dev. 24:72–85.
   PubMed Web of Science ®Google Scholar
• Zhao, R., et al. 2011. Long isoforms of NRF1 contribute to arsenic-induced antioxidant response in human keratinocytes. Environ. Health Perspect. 119:56–62.
   PubMed Web of Science ®Google Scholar